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Summary 
The cellular processes in which snoRNAs participate are fundamental processes needed for 
proper cell function, yet their roles in cell differentiation, homeostasis and disease in general 
have been poorly investigated. Moreover, in the context of chondrogenic differentiation, 
cartilage homeostasis and disease, snoRNAs have not been investigated so far. In the work 
presented in this thesis we therefore investigated the involvement of snoRNAs in several 
chondrocyte and cartilage facets.  
 
Chapter 2 Expression of RMRP RNA is regulated in chondrocyte 
hypertrophy and determines chondrogenic differentiation 
Mutations in the RMRP-gene, encoding the snoRNA component of the RNase MRP complex, 
are the cause of cartilage-hair hypoplasia (CHH)1,2. CHH is associated with severe dwarfism 
caused by impaired skeletal development. However, it is not clear why mutations in RMRP 
snoRNA lead to skeletal dysplasia. Since chondrogenic differentiation of the growth plate is 
required for development of the long bones, we hypothesized that the RMRP snoRNA plays 
a pivotal role in chondrogenic differentiation. Expression of Rmrp RNA and RNase MRP 
protein subunits was detected in the murine growth plate and during the course of 
chondrogenic differentiation of ATDC5 cells, where Rmrp RNA expression was found to be 
correlated with chondrocyte hypertrophy. Genetic interference with Rmrp RNA expression in 
ATDC5 cells caused a deregulation of chondrogenic differentiation, with a prominent impact 
on hypertrophy and changes in pre-rRNA processing and rRNA levels (reduced levels of 18S 
and 5.8S rRNA). Promoter reporter studies showed that Rmrp RNA expression responds to 
chondrogenic morphogens such as PTHrP and bFGF (reduced promoter activity) and TGFβ3, 
BMP-2, WNT-3A and WNT-5A (increased promoter activity). Chondrogenic trans-
differentiation of CHH fibroblasts was impaired with a pronounced impact on hypertrophic 
differentiation, increased levels of PTHrP and accumulation of the ITS-1 pre-rRNA processing 
intermediate. Together, our data show that RMRP RNA expression is regulated during 
different stages of chondrogenic differentiation and indicate that RMRP RNA may play a 
pivotal role in chondrocyte hypertrophy, with potential consequences for CHH 
pathobiology3. 
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Chapter 3 The anti-viral protein viperin regulates chondrogenic 
differentiation via CXCL10 protein secretion 
RNase MRP has a number of substrate RNAs and from most it is not clear how these 
substrate RNAs may influence cell biological processes, nor is it known how these substrates 
may be involved in the development of CHH or chondrogenic differentiation. One of these 
substrate RNAs is the mRNA of viperin4. Viperin, an abbreviation for Virus Inhibitory Protein, 
Endoplasmic Reticulum-associated, Interferon (IFN)-inducible, is a protein located in the 
endoplasmic reticulum5 and it is well described for its role as an antiviral protein6. Viperin 
expression has been shown to be increased in CHH leukocytes7 and following knockdown of 
RNase MRP subunits4. We discovered that viperin is expressed in differentiating 
chondrocytic cells and regulates their protein secretion and the outcome of chondrogenic 
differentiation by influencing TGF-β/SMAD2/3 activity via CXCL10, where CXCL10 inhibits 
chondrogenic differentiation. Moreover, we observed disturbances in this viperin–CXCL10–
TGF-β/SMAD2/3 axis in CHH chondrocytic cells. Our results indicate that the anti-viral 
protein viperin controls chondrogenic differentiation by influencing secretion of soluble 
proteins and we identified a molecular route that may explain impaired chondrogenic 
differentiation of cells from individuals with CHH8. 
 
Chapter 4 Adaptation of protein translational apparatus during ATDC5 
chondrogenic differentiation 
The RMRP snoRNA is one highly specific snoRNA belonging to a small group of non-canonical 
snoRNAs. The majority of the cell’s snoRNAs however belong to a group of canonical 
snoRNAs involved in the post-transcriptional modification of rRNAs. Fine-tuning of the cell’s 
rRNA pool by snoRNA-mediated post-transcriptional modifications is believed to determine 
ribosome activity and control ribosome translation fidelity. It is expected that this is 
particularly important in translationally active cells, like growth plate chondrocytes, in order 
to accurately and efficiently synthesize the proteins required for building the cartilaginous 
growth plate extracellular matrix and support their high speed of proliferation. We therefore 
charted the full spectrum of snoRNAs expressed during different phases of chondrogenic 
differentiation. snoRNAs were found to be differentially expressed during ATDC5 
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chondrogenic differentiation. In addition, rRNA post-transcriptional modifiers, the 2’O-ribose 
methylase fibrillarin and the pseudouridylase dyskerin, as well as UBF-1 (involved in rDNA 
transcription) expression and 18S, 5.8S and 28S rRNA content per cell adapted to the 
differentiation status of ATDC5 cells. Overall an impact on the translational capacity of the 
cell, depending on the differentiation status of the ATDC5 cells, was demonstrated. Thus, our 
data showed that chondrogenic differentiation is associated with significant regulation of 
mechanisms involving ribosome biogenesis and translation activity. Differentiation-phase 
specific expression of snoRNAs suggests that specific snoRNAs may modulate the 
chondrocyte’s developing phenotype via an rRNA post-transcriptional modification-based 
ribosome heterogeneity mechanism, thereby potentially facilitating the observed dynamics 
in translational activity impacting the course of chondrogenic differentiation. Future work is 
expected to uncover the extent of ribosome heterogeneity and regulation in cellular 
differentiation and its potential implications for human disease. 
 
Chapter 5 Serum snoRNAs as biomarkers for joint ageing and post-
traumatic osteoarthritis  
In osteoarthritis, like in chondrogenic differentiation, the chondrogenic phenotype is actively 
changing9. The development of effective treatments for the age-related disease 
osteoarthritis and the ability to predict disease progression has been hampered by the lack 
of biomarkers able to demonstrate the course of the disease. Profiling the expression 
patterns of snoRNAs in murine joint ageing and osteoarthritis may provide insight in their 
contribution to joint pathology, their use as diagnostic biomarkers and potential as 
therapeutic targets. SnoRNASeq identified differential expression of 6 snoRNAs in young 
versus old joints and 5 snoRNAs in old sham versus old experimental osteoarthritic joints. In 
serum we found differential presence of 27 snoRNAs in young versus old serum and 18 
snoRNAs in old sham versus old experimental osteoarthritic serum. Profiling the expression 
patterns of snoRNAs is the initial step in determining their functional significance in ageing 
and osteoarthritis, and provides potential diagnostic biomarkers and therapeutic targets. 
Our results established snoRNAs as novel markers of musculoskeletal ageing and 
osteoarthritis and implicate specific changes in snoRNA abundance in joint ageing (SNORD88 
and SNORD38 were respectively decreased and increased) and OA, suggesting the potential 
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use of snoRNAs such as SNORA73 and SNORD23 as a novel biomarker for joint ageing, 
SNORA64, SNORD46 and SNORD116 for OA, SNORD18 for ageing and OA10.  
 
Conclusions 
In the general discussion the data described in this thesis were discussed with respect to 
each other and with outsight to future directions for snoRNA research in cartilaginous 
tissues. In addition, we provided an overview of the molecular interactions identified from 
this thesis. Overall, the work presented in this thesis provides directions for pathways in 
which snoRNAs function in chondrocyte development and disease. 
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